Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: zurdo who wrote (2817)	5/23/1998 3:53:00 PM
From: BigKNY3	Read Replies (2) \| Respond to of 9523

From today's Barrons: Pfizer dropped 3 11/16 Friday to 105 7/16 after disclosing that six people died while taking its impotence drug, Viagra. Some analysts downplayed the news, saying that the number of deaths is small in a patient population of a million, most of whom are older men. In addition, it isn't clear whether the deaths were related to the drug. Pfizer has disclosed that some deaths occurred during clinical trials. Still, the news was an excuse for profit-taking in a stock that has doubled in the past year and trades at an industry-high 50 times projected 1998 profits. BigKNY3